Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.

Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR.

Science. 2008 Dec 12;322(5908):1702-5. doi: 10.1126/science.1161524.

2.

Rare variant APOC3 R19X is associated with cardio-protective profiles in a diverse population-based survey as part of the Epidemiologic Architecture for Genes Linked to Environment Study.

Crawford DC, Dumitrescu L, Goodloe R, Brown-Gentry K, Boston J, McClellan B Jr, Sutcliffe C, Wiseman R, Baker P, Pericak-Vance MA, Scott WK, Allen M, Mayo P, Schnetz-Boutaud N, Dilks HH, Haines JL, Pollin TI.

Circ Cardiovasc Genet. 2014 Dec;7(6):848-53. doi: 10.1161/CIRCGENETICS.113.000369. Epub 2014 Nov 1.

3.

A high-carbohydrate diet enhances the adverse effect of the S2 allele of APOC3 SstI polymorphism on the TG/HDL-C ratio only in young Chinese females.

Song YY, Gong RR, Zhang Z, Li YH, Xiao LY, Zhou XD, Fang DZ.

Braz J Med Biol Res. 2011 Jun;44(6):524-30. Epub 2011 May 20.

4.

Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.

Qamar A, Khetarpal SA, Khera AV, Qasim A, Rader DJ, Reilly MP.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1880-8. doi: 10.1161/ATVBAHA.115.305415. Epub 2015 Jun 11.

5.

Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang HM, Xue C, Goel A, Farrall M, Duga S, Merlini PA, Asselta R, Girelli D, Olivieri O, Martinelli N, Yin W, Reilly D, Speliotes E, Fox CS, Hveem K, Holmen OL, Nikpay M, Farlow DN, Assimes TL, Franceschini N, Robinson J, North KE, Martin LW, DePristo M, Gupta N, Escher SA, Jansson JH, Van Zuydam N, Palmer CN, Wareham N, Koch W, Meitinger T, Peters A, Lieb W, Erbel R, Konig IR, Kruppa J, Degenhardt F, Gottesman O, Bottinger EP, O'Donnell CJ, Psaty BM, Ballantyne CM, Abecasis G, Ordovas JM, Melander O, Watkins H, Orho-Melander M, Ardissino D, Loos RJ, McPherson R, Willer CJ, Erdmann J, Hall AS, Samani NJ, Deloukas P, Schunkert H, Wilson JG, Kooperberg C, Rich SS, Tracy RP, Lin DY, Altshuler D, Gabriel S, Nickerson DA, Jarvik GP, Cupples LA, Reiner AP, Boerwinkle E, Kathiresan S.

N Engl J Med. 2014 Jul 3;371(1):22-31. doi: 10.1056/NEJMoa1307095. Epub 2014 Jun 18.

6.

Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Song Y, Zhu L, Richa M, Li P, Yang Y, Li S.

Lipids Health Dis. 2015 Apr 18;14:32. doi: 10.1186/s12944-015-0027-0.

7.

Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis: The Multi-Ethnic BioImage Study.

Natarajan P, Kohli P, Baber U, Nguyen KH, Sartori S, Reilly DF, Mehran R, Muntendam P, Fuster V, Rader DJ, Kathiresan S.

J Am Coll Cardiol. 2015 Nov 3;66(18):2053-2055. doi: 10.1016/j.jacc.2015.08.866. No abstract available.

8.

Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.

Shen H, Damcott CM, Rampersaud E, Pollin TI, Horenstein RB, McArdle PF, Peyser PA, Bielak LF, Post WS, Chang YP, Ryan KA, Miller M, Rumberger JA, Sheedy PF 2nd, Shelton J, O'Connell JR, Shuldiner AR, Mitchell BD.

Arch Intern Med. 2010 Nov 8;170(20):1850-5. doi: 10.1001/archinternmed.2010.384.

9.

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A.

N Engl J Med. 2014 Jul 3;371(1):32-41. doi: 10.1056/NEJMoa1308027. Epub 2014 Jun 18.

10.

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

Onat A, Hergenç G, Sansoy V, Fobker M, Ceyhan K, Toprak S, Assmann G.

Atherosclerosis. 2003 May;168(1):81-9.

PMID:
12732390
11.

Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency.

Garenc C, Couillard C, Laflamme N, Cadelis F, Gagné C, Couture P, Julien P, Bergeron J.

Eur J Hum Genet. 2005 Oct;13(10):1159-65.

12.

Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR.

Nat Genet. 2008 Feb;40(2):161-9. doi: 10.1038/ng.76. Epub 2008 Jan 13.

13.

[Relation between apolipoprotein CIII gene polymorphism and coronary artery disease].

Liu SK, Mu X, Yang YY, Xu Q, Wang XM, Ding RJ, Zhang ZC.

Zhonghua Yi Xue Za Zhi. 2007 Apr 24;87(16):1133-5. Chinese.

PMID:
17672999
14.

APOE, CETP and LPL genes show strong association with lipid levels in Greek children.

Smart MC, Dedoussis G, Louizou E, Yannakoulia M, Drenos F, Papoutsakis C, Maniatis N, Humphries SE, Talmud PJ.

Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):26-33. doi: 10.1016/j.numecd.2009.02.005. Epub 2009 Apr 28.

15.

Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.

Ruixing Y, Yiyang L, Meng L, Kela L, Xingjiang L, Lin Z, Wanying L, Jinzhen W, Dezhai Y, Weixiong L.

Lipids Health Dis. 2010 Aug 17;9:86. doi: 10.1186/1476-511X-9-86.

16.

[Mutations of APOC3 gene, metabolism of triglycerides and reduction of ischemic cardiovascular events].

Pirillo A, Catapano AL.

G Ital Cardiol (Rome). 2015 May;16(5):289-94. doi: 10.1714/1870.20430. Italian.

PMID:
25994465
17.

Genetic determination of plasma lipids and insulin in the Czech population.

Hubacek JA, Waterworth DM, Poledne R, Pitha J, Skodová Z, Humphries SE, Talmud PJ.

Clin Biochem. 2001 Mar;34(2):113-8.

PMID:
11311220
18.

The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia.

Kolovou GD, Anagnostopoulou KK, Pilatis ND, Giannopoulou M, Hoursalas IS, Pavlidis AN, Adamopoulou E, Valaora AI, Mikhailidis DP, Cokkinos DV.

J Womens Health (Larchmt). 2004 Dec;13(10):1119-26.

PMID:
15650345
19.

Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.

Yu J, Huang J, Liang Y, Qin B, He S, Xiao J, Wang H, Zhong R.

Lipids Health Dis. 2011 Nov 4;10:200. doi: 10.1186/1476-511X-10-200.

20.

Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.

Barr SI, Kottke BA, Mao SJ.

Am J Clin Nutr. 1981 Feb;34(2):191-8.

PMID:
7211723

Supplemental Content

Support Center